Shang-lang Huang
Dawan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
H1.0 modulates IL-6 expression and paclitaxel resistance via HDAC5 in ovarian cancer cells.
Journal: Biochemical pharmacology
Published: November 21, 2024
Curcumin reduces paclitaxel resistance in ovarian carcinoma cells by upregulating SNIP1 and inhibiting NFκB activity.
Journal: Biochemical pharmacology
Published: February 20, 2023
TLR4/IL-6/IRF1 signaling regulates androgen receptor expression: A potential therapeutic target to overcome taxol resistance in ovarian cancer.
Journal: Biochemical pharmacology
Published: November 18, 2020
Role of the TLR4-androgen receptor axis and genistein in taxol-resistant ovarian cancer cells.
Journal: Biochemical pharmacology
Published: January 10, 2020
TLR4 and NFκB signaling is critical for taxol resistance in ovarian carcinoma cells.
Journal: Journal of cellular physiology
Published: January 16, 2017
Integrative transcriptomics-based identification of cryptic drivers of taxol-resistance genes in ovarian carcinoma cells: Analysis of the androgen receptor.
Journal: Oncotarget
Published: March 17, 2015
Transcriptomic profiling of taxol-resistant ovarian cancer cells identifies FKBP5 and the androgen receptor as critical markers of chemotherapeutic response.
Journal: Oncotarget
Published: August 25, 2014
Sorafenib induces endometrial carcinoma apoptosis by inhibiting Elk-1-dependent Mcl-1 transcription and inducing Akt/GSK3β-dependent protein degradation.
Journal: Journal of cellular biochemistry
Published: February 15, 2013
Golgi-SNARE GS28 potentiates cisplatin-induced apoptosis by forming GS28-MDM2-p53 complexes and by preventing the ubiquitination and degradation of p53.
Journal: The Biochemical journal
Published: March 09, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026